Latest News

The Yale Multidisciplinary Endocrine Neoplasia Clinic has been treating benign and malignant diseases of the thyroid, parathyroid, adrenal, and pituitary glands since 2013. The program is a collaboration between the Department of Internal Medicine’s Section of Endocrinology & Metabolism and Yale Cancer Center and Smilow Cancer Hospital.

Discoveries & Impact highlights select scientific discoveries across the Department of Internal Medicine...

Yale Cancer Center’s Annual Conclave was held on January 5, 2023 to recognize scientific and clinical accomplishments of the Center's faculty and staff in 2022. Dr. Eric Winer hosted the event and presented research awards in four categories.

The Department of Internal Medicine is pleased to welcome the following new faculty, staff members, and postdoctoral associates who joined us in December 2022...

Three Department of Internal Medicine staff are set to retire. Kathleen Marcucio from the Section of Endocrinology & Metabolism retired on December 31, 2022. Susan Ardito from the Section of Pulmonary, Critical Care & Sleep Medicine (Yale-PCCSM), and Elizabeth “Beth” Porter from the Section of General Internal Medicine retire in January 2023.

A new FDA-approved drug delays the onset of type 1 diabetes and the need for insulin injections for several years.

Designed for diabetes but used for obesity at higher doses, the medications induce loss of 15 to 22 percent of body weight on average — more than enough to significantly reduce cardiovascular and other health risks. That makes them far superior to old-style diet pills that delivered smaller benefits along with nasty side effects such as high blood pressure and loose stools.

Ania Jastreboff, MD, PhD talks about obesity.

Meet Tracy Crosby, Clinical Operations Manager; Fellowship Coordinator, Section of Endocrinology & Metabolism (Internal Medicine)